Physician profile
Paul Cohen
NPI 1760462436
$1,532.77
in general payments reported to CMS, 2019-2025
18 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $125 · 2021: $284 · 2022: $361 · 2023: $104 · 2024: $283 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $589.23 | 2019-2025 | Skyrizi, Mavyret |
| Celgene Corporation | $183.54 | 2023-2024 | Zeposia |
| Redhill Biopharma INC. | $134.25 | 2020-2022 | |
| Intercept Pharmaceuticals, INC. | $84.00 | 2019-2021 | |
| Braintree Laboratories, INC. | $77.64 | 2021-2022 | |
| Gilead Sciences, INC. | $70.60 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $68.15 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.86 | 2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.56 | 2021 | |
| Boston Scientific Corporation | $34.35 | 2023 | Watchman Access System |
| Phathom Pharmaceuticals, INC. | $29.44 | 2024 | Voquezna |
| Janssen Biotech, INC. | $24.61 | 2025 | Tremfya |
| Shield Therapeutics INC | $23.39 | 2025 | |
| Qiagen, LLC | $21.20 | 2020 | |
| Qol Medical, LLC | $20.74 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.32 | 2024 | Zepbound, Omvoh |
| Allergan, INC. | $16.67 | 2019 | |
| Abbott Laboratories | $14.22 | 2023 | Freestyle Libre 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.